Literature DB >> 14753756

Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.

Su Duy Nguyen1, Dai-Eun Sok.   

Abstract

Paraoxonase1 (PON1), one of antioxidant proteins to protect low density lipoprotein (LDL) from the oxidation, is known to lose its activity in the oxidative environment. Here, we attempted to elucidate the possible mechanisms for the oxidative inactivation of PON1, and to examine the capability of hydroxyl radicals-inactivated PON1 to prevent against LDL oxidation. Of various oxidative systems, the ascorbate/Cu2+ system was the most potent in inactivating the purified PON1 (PON1) as well as HDL-bound PON1 (HDL-PON1). In contrast to a limited inactivation by Fe2+ (2.0 microM), the inclusion of Cu2+ (0.1-1.0 microM) remarkably enhanced the inactivation of PON1 in the presence of ascorbate (0.5mM). A similar result was also obtained with the inactivation of HDL-PON1. The inactivation of PON1 by ascorbate/Cu2+ was pevented by catalase, but not general hydroxyl radical scavengers, supporting inactivation. In addition, Cu2+ alone inactivated PON1, either soluble or HDL-bound, by different mechanisms, concentration-dependent. Separately, there was a reverse relationship between the inactivation of PON1 and its preventive action against LDL oxidation during Cu2+-induced oxidation of LDL. Noteworthy, ascorbate/Cu2+-inactivated PON1, which was charaterized by the partial loss of histidine residues, expressed a lower protection against Cu2+-induced LDL oxidation, compared to native PON1. Based on these results, it is proposed that metal-catalyzed oxidation may be a primary factor to cause the decrease of HDL-associated PON1 activity under oxidative stress, and radicals-induced inactivation of PON1 may lead to the decrease in its antioxidant action against LDL oxidation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753756

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  17 in total

Review 1.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Authors:  Lucio G Costa; Gennaro Giordano; Clement E Furlong
Journal:  Biochem Pharmacol       Date:  2010-11-18       Impact factor: 5.858

2.  The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants.

Authors:  Mahmut Abuhandan; Alpay Cakmak; Abdullah Taskın; Emrah Karakaya; Abdurrahim Kocyigit; Hatip Kılıc
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

Review 3.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

4.  Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy.

Authors:  Hande Koksal; Sevil Kurban
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

Review 5.  Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Authors:  Lucio G Costa; Gennaro Giordano; Toby B Cole; Judit Marsillach; Clement E Furlong
Journal:  Toxicology       Date:  2012-07-31       Impact factor: 4.221

6.  The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.

Authors:  Muhammad Muddasir Qureshi; Warren C McClure; Nicole L Arevalo; Rick E Rabon; Benjamin Mohr; Swapan K Bose; Joe M McCord; Brian S Tseng
Journal:  J Diet Suppl       Date:  2010-06-01

7.  Regulation of hepatic paraoxonase-1 expression.

Authors:  Bianca Fuhrman
Journal:  J Lipids       Date:  2012-04-03

8.  Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease.

Authors:  O Hussein; J Zidan; K Abu Jabal; I Shams; S Szvalb; M Grozovski; I Bersudsky; R Karry; M Aviram
Journal:  Int J Hepatol       Date:  2012-03-27

9.  Paraoxonase and arylesterase activities, lipid profile, and oxidative damage in experimental ischemic colitis model.

Authors:  Ethem Unal; Cengiz Eris; Bülent Kaya; Hafize Uzun; Faruk Cavdar; Murat Yildar; Ali Riza Kiziler; Birsen Aydemir; Pembegul Gunes; Riza Kutanis; Izzet Titiz
Journal:  Gastroenterol Res Pract       Date:  2012-11-12       Impact factor: 2.260

10.  Novel associations of nonstructural Loci with paraoxonase activity.

Authors:  Ellen E Quillen; David L Rainwater; Thomas D Dyer; Melanie A Carless; Joanne E Curran; Matthew P Johnson; Harald H H Göring; Shelley A Cole; Sue Rutherford; Jean W Maccluer; Eric K Moses; John Blangero; Laura Almasy; Michael C Mahaney
Journal:  J Lipids       Date:  2012-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.